Find out more ways to treat psoriasis in the future

Published Date: 02 Mar 2023

According to MBA MD Andrew Blauvelt, the development of oral biologics and early treatment to replace the disease is a possibility.

Read Full News

Latest News

Distinct Comorbidity Pattern Hinders Remission in Lupus

Patients with lupus face a high burden of comorbidities, with the presence of at least one of seven key conditions linked to 55%-60% lower odds of achieving remission or a low disease activity state.

Children With Autism Face Growing Unmet Healthcare Needs

A cross-sectional study examines annual trends in unmet healthcare needs among over 8000 children with autism.

Secukinumab Gets FDA Nod for Adolescent HS

Weight-based injectable’s approval is based in part on other pediatric indications.

HSV-1 May Be Increasing in Infants

A new study suggests that HSV-1 has become the dominant subtype among newborns.

Low-Beta Radiation Patch Offers Alternative NMSC Treatment

Similar to brachytherapy, OncoPatch could be an option for patients who have superficial lesions or who aren’t surgical candidates.

UK Approves New JAK Inhibitor for Severe Alopecia

Deuruxolitinib is the latest JAK inhibitor to enter the UK alopecia areata treatment landscape, pending a NICE decision on NHS access.

Todays Updates

Older Adults With Advanced Cancer Prioritize Quality of Life

Most older adults with advanced cancer value quality of life over extending survival, but that preference may not translate to clinical care or outcomes.

Todays Updates

Older Adults With Advanced Cancer Prioritize Quality of Life

Most older adults with advanced cancer value quality of life over extending survival, but that preference may not translate to clinical care or outcomes.

Latest News

Patients with lupus face a high burden of comorbidities, with the presence of at least one of seven key conditions linked to 55%-60% lower odds of achieving remission or a low disease activity state.

A cross-sectional study examines annual trends in unmet healthcare needs among over 8000 children with autism.

Weight-based injectable’s approval is based in part on other pediatric indications.

A new study suggests that HSV-1 has become the dominant subtype among newborns.

Similar to brachytherapy, OncoPatch could be an option for patients who have superficial lesions or who aren’t surgical candidates.

Deuruxolitinib is the latest JAK inhibitor to enter the UK alopecia areata treatment landscape, pending a NICE decision on NHS access.

News All Time

PIP Matches PrEP for Low-Risk HIV

The use of medicine at home offers convenience and curbs costs.

Can Physical Activity Improve Skin Cancer Outcomes?

Physical activity is associated with a reduced risk for all-cause mortality and improved survival in patients with skin cancer, a meta-analysis shows.

Healthy Diet May Cut Cancer Survivors’ Premature Aging Risk

A recent study found reduced premature aging among childhood cancer survivors that adhered to established dietary guidelines.

AI Tools Helpful With Prior Auth Letters, Handouts, and More

‘Specify everything you need, do it as if you’re talking to your medical assistant,’ one dermatologist recommends.

Study Identifies Factors Linked to Early Melanoma Recurrence

Several clinicopathologic features beyond tumor thickness and ulceration are associated with recurrence risk in patients with localized stage I-II melanoma.

Antimalarials May Cut RA and SLE Hospital Admissions, Stays

Patients with RA or SLE who adhere to antimalarial therapy have a lower risk for hospital admission and fewer days of hospital stay than their nonadherent peers.

Can Fecal Transplants Enhance Immunotherapy? New Evidence

Fecal microbiota transplants may enhance patients’ response to immunotherapy, but experts caution that the latest data remain proof-of-concept and far from practice-changing.

Expert Meeting on US Measles Elimination Status Delayed to November

A meeting of an international panel of experts that was set to review the United States' measles ⁠elimination status next month has been postponed until November, the Pan...

Melanoma Cases Top Skin Cancer Lawsuits

A review finds melanoma accounts for nearly half of skin cancer malpractice cases, with delayed diagnosis being the leading allegation.

CSF Biomarkers Suggest Impact of Herpes on Brain Health

Biomarkers for Alzheimer’s disease are linked to latent infection in people with HIV.

MHRA Clears Brensocatib for Bronchiectasis

The MHRA has licensed brensocatib as the first disease-specific therapy for non-cystic fibrosis bronchiectasis in patients with recurrent exacerbations.

Bimekizumab Improves Hidradenitis Suppurativa Severity

Bimekizumab yields clinically meaningful improvements in the severity of hidradenitis suppurativa over 48 weeks, shifting most patients to a mild disease, a pooled analysis of two trials shows.

Americans Trust Vaccines, School Mandates, Rejecting Trump Agenda, Reuters/Ipsos Poll Finds

A bipartisan majority of Americans believe vaccines are safe and that children should receive them to attend school, according to a new Reuters/Ipsos poll, illustrating the...

New Mental Health Disorders Tied to Early Cancer Mortality

In a decade-long analysis of University of California health system data, researchers assess early-onset mental health disorders after cancer diagnosis and subsequent survival trends.

NHS to Fund Ruxolitinib for Vitiligo

NICE has recommended topical ruxolitinib for facial non-segmental vitiligo in patients aged 12 or over after a revised cost review.

Recommended News For You

Cancer research in the US is world class. With the government pulling out, its future is uncertain

COVID Lockdowns Significantly Increasing Children's Vitamin D Deficiency?

MCh in Surgical Oncology: Admission, Medical School, Fees, Qualifications Information

TRK Inhibitor Active in Treatment-Refractory Glioblastoma

A study on lung cancer provides additional proof of the value of screening.

AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancer

AI Unlocks Benefits of Prostate Cancer Treatment.

Recommended Articles For You

The Pros and Cons of Using Cyclophosphamide in Cancer Treatment  

A Review on Genetic Predispositions and Clinical Advancements of Multiple Myeloma Cancer 

The Importance of Early Detection in Angiosarcoma: A Story of Survival  

Understanding Epidural Hematoma: Symptoms, Causes and Treatment  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment

2.

These Medical Doctors Are Real Comedians: Should Doctors Be Funnier?

3.

PSMA-PET/CT Detects Metastatic Prostate Cancer Missed by Other Imaging

4.

Researchers explore e-bikes for cancer recovery

5.

Results for Prostate Cancer Are Associated With PSA Nadir 6 Months After Primary RT.

1.

Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence

2.

Personalized Neoantigen Vaccines and the Promise of a Less Toxic Future in Pediatric Oncology

3.

Unlocking the Potential of Leukemia Treatment: A New Hope for Patients

4.

Breast Cancer Recovery: Fashion, Function, and Healing Beyond Scars

5.

Antibody-Drug Conjugates in Oncology: Breakthroughs, Clinical Updates, and Pipeline Innovation

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

2.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

4.

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

5.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot